James Cameron explains why Avengers: Endgame's box office victory quelled his biggest fear about Avatar 2


Director James Cameron is actually pretty psyched there's a new king of the film world.
Cameron's Avatar was dethroned by Avengers: Endgame as the highest-grossing movie of all time in July after a decade at the top. But the filmmaker, who also previously held the box office record for Titanic, told Deadline on Wednesday that Endgame's stunning accomplishment actually brought him "a lot of hope."
That's not just him being a good sport; Cameron explained the movie's success put him at ease about today's movie-going environment as he prepares to release not one but four Avatar sequels.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"Avengers: Endgame is demonstrable proof that people will still go to movie theaters," Cameron told Deadline. "The thing that scared me most about making Avatar 2 and Avatar 3 was that the market might have shifted so much that it simply was no longer possible to get people that excited about going and sitting in a dark room with a bunch of strangers to watch something. ... I'm happy to see it."
Of course, Cameron is suggesting this means Avatar 2 can knock Endgame off its perch when it thunders into theaters in two years; the director offered a "who knows" about whether his sequel can be as successful as its 2009 predecessor, but he said it's certainly "possible." Look out, Marvel: Cameron's coming back to reclaim his title once again in December 2021. Now that's an Avengers-level threat.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Jasveen Sangha and the ketamine 'Wild West' of Hollywood
In The Spotlight Arrest of the 'ketamine queen' accused of supplying Friends star Matthew Perry with deadly dose has turned spotlight on a showbiz drug problem
-
Confessions of a Brain Surgeon: an 'exceptional' documentary
The Week Recommends Retired neurosurgeon Henry Marsh reflects on his pioneering work with exquisitely 'raw honesty'
-
A new subtype of diabetes was found and it may require different treatment
Under the radar It is prevalent in Black Africans and Americans
-
Trump said to seek government stake in Intel
Speed Read The president and Intel CEO Lip-Bu Tan reportedly discussed the proposal at a recent meeting
-
US to take 15% cut of AI chip sales to China
Speed Read Nvidia and AMD will pay the Trump administration 15% of their revenue from selling artificial intelligence chips to China
-
NFL gets ESPN stake in deal with Disney
Speed Read The deal gives the NFL a 10% stake in Disney's ESPN sports empire and gives ESPN ownership of NFL Network
-
Samsung to make Tesla chips in $16.5B deal
Speed Read Tesla has signed a deal to get its next-generation chips from Samsung
-
FCC greenlights $8B Paramount-Skydance merger
Speed Read The Federal Communications Commission will allow Paramount to merge with the Hollywood studio Skydance
-
Tesla reports plummeting profits
Speed Read The company may soon face more problems with the expiration of federal electric vehicle tax credits
-
Dollar faces historic slump as stocks hit new high
Speed Read While stocks have recovered post-Trump tariffs, the dollar has weakened more than 10% this year
-
Economists fear US inflation data less reliable
speed read The Labor Department is collecting less data for its consumer price index due to staffing shortages